59 results
Page 2 of 3
424B5
ox9w03o0n0 2va6u5
20 Jan 22
Prospectus supplement for primary offering
4:45pm
424B5
w8cyhduecyj2806
17 Nov 21
Prospectus supplement for primary offering
9:02am
424B5
v1e5x5dtz jhm4a65
15 Nov 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
xkbscql0hplla1rva5
27 Oct 20
Sobi obtains global co-development and exclusive ex-U.S. commercialization rights for systemic pegcetacoplan, a targeted C3 therapy
7:17am
424B5
sb9wff2
9 Jan 20
Prospectus supplement for primary offering
5:25pm
424B5
q7166s ou
7 Jan 20
Prospectus supplement for primary offering
4:19pm
S-3ASR
6p9zdqv2f0wp
7 Jan 20
Automatic shelf registration
4:01pm